| Angela Auerbach, | |
|
5101 Sw 113th Ave, Fort Lauderdale, FL 33330-2826 | |
| (954) 680-0626 | |
| Not Available |
| Full Name | Angela Auerbach |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5101 Sw 113th Ave, Fort Lauderdale, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073054516 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 6451 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Auerbach, 5101 Sw 113 Avenue, Fort Lauderdale, FL 33330 Ph: (954) 680-0626 | Angela Auerbach, 5101 Sw 113th Ave, Fort Lauderdale, FL 33330-2826 Ph: (954) 680-0626 |
News Archive
Recalls of ground beef, peanut butter, and other foods have done more than raise public awareness and concern about food safety. They also are quietly fueling a boom in the market for food testing equipment and fostering new food safety regulations. That's the topic of the two-part cover story in the current issue of Chemical & Engineering News, (C&EN) ACS' weekly newsmagazine.
Massachusetts College of Pharmacy and Health Sciences today officially opened a new 30,000 square foot, $10M academic center at 40 Foster St. in downtown Worcester. On hand at the event were Congressman Jim McGovern (D-MA), Worcester City Manager Michael O'Brien, Worcester Mayor Konstantina Lukes and MCPHS President Charles F. Monahan Jr.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
MIT researchers have discovered a way to make bacteria more vulnerable to a class of antibiotics known as quinolones, which include ciprofloxacin and are often used to treat infections such as Escherichia coli and Staphylococcus aureus.
› Verified 8 days ago
Miss Anat Rosa Codinach, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5317 Sw 33rd Ter, Fort Lauderdale, FL 33312 Phone: 954-290-6284 | |
Victoria Hilliard, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1741 Ne 56th St Apt 2, Fort Lauderdale, FL 33334 Phone: 954-303-2179 | |
Fort Lauderdale Hand Clinic Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2000 W Commercial Blvd, Suite 101, Fort Lauderdale, FL 33309 Phone: 954-351-0511 Fax: 954-351-0411 | |
Rachel Morgan Iserson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1790 Sw 43rd Way, Fort Lauderdale, FL 33317 Phone: 855-442-2454 | |
Barbara Mandrisch, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1458 Sw 19th Ave, Fort Lauderdale, FL 33312 Phone: 305-761-5139 | |
Mrs. Tracey Lynn Minkin, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1031 Seminole Dr, Fort Lauderdale, FL 33304 Phone: 954-780-5627 |